INE199A01012
INE199A01012
PROCTER & GAMBLE HEALTH LIMITE
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 86.57B EUR | 105.06B EUR | 79.65B EUR | 94.64B EUR |
Enterprise Value | 127.59B EUR | 105.06B EUR | 77.97B EUR | 94.64B EUR |
Valuation Multiples | ||||
Trailing P/E | 24.24x | 29.44x | 24.36x | 40.74x |
Forward P/E | 21.19x | -- | -- | -- |
Price to Sales | 6.04x | 7.33x | 5.66x | 9.12x |
Price to Book | 16.5x | -- | 15.18x | -- |
EV/Revenue | 8.9x | 7.33x | 5.54x | 9.12x |
EV/EBITDA | 27.35x | 21.75x | 16.45x | 28.3x |
Price to FCF (P/FCF) | -- | -- | -- | 205.78x |
EV/FCF | -- | -- | -- | 205.78x |
FCF Yield | -- | -- | -- | 0.49% |